| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 3.07 | 19.7% | 90.7% |
| Total Income | 3.07 | 19.9% | 90.9% |
| Expenditure | 2.02 | 0.7% | 2.7% |
| PBT | 1.05 | 99.8% | 392.2% |
| Net Profit | 0.84 | 92.1% | 285.8% |
| OPM | 53.92% | 56.14pp | 39.80pp |
| NPM | 27.25% | 10.25pp | 55.24pp |
| EPS | 1.82 | 91.6% | 85.7% |
Caprolactam Chemicals: FY26 Revenue at ₹1,055.75 Lakhs
30 May 2026 · 30 May, 5:31 pm
Summary
Caprolactam Chemical Limited delivered a strong performance for both the fourth quarter and the full financial year ended March 31, 2026. Q4 FY26 revenue from operations rose by 90.68% year-on-year to ₹306.70 lakhs, driving the company to a profit after tax of ₹83.76 lakhs, a significant turnaround from a loss in the prior year. For the full fiscal year 2026, revenue from operations increased by 56.69% to ₹1,055.75 lakhs, with the company successfully returning to profitability, reporting a profit after tax of ₹176.12 lakhs. This marks a substantial improvement from the losses incurred in the previous fiscal year, reflecting a positive operational and financial shift.
Key Highlights
- 1
Caprolactam Chemical Limited reported a substantial increase in revenue from operations for Q4 FY26, growing by 90.68% year-on-year to ₹306.70 lakhs.
- 2
The company achieved a significant turnaround in Q4 FY26, posting a profit after tax of ₹83.76 lakhs, compared to a loss of ₹(35.07) lakhs in Q4 FY25.
- 3
For the full financial year 2026, revenue from operations surged by 56.69% to ₹1,055.75 lakhs, up from ₹673.96 lakhs in FY25.
- 4
Caprolactam Chemical Limited successfully turned profitable for FY26, reporting a profit after tax of ₹176.12 lakhs, a stark contrast to the loss of ₹(70.87) lakhs recorded in FY25.
- 5
Basic and Diluted Earnings Per Share for FY26 stood at ₹3.83, a notable improvement from a loss per share of ₹(1.54) in the previous fiscal year.
- 6
The company's total comprehensive income for FY26 also saw a positive shift, reaching ₹175.29 lakhs compared to a loss of ₹(71.83) lakhs in FY25.
- 7
The Board of Directors approved the appointment of M/s. Shrey Pandey & Associates as an Internal Auditor for Financial Year 2026-27.
Informational and educational content only. Not investment advice.